Direct detection of blood doping is relatively time-consuming and cost intensive. Some of the banned substances, such as recombinant human erythropoietin (rhEPO), can hardly be distinguished from natural, endogenous hormones. This SEED describes how it is nevertheless possible to indirectly detect EPO-like doping with a modern haematology analyser like the XN-Series and reticulocyte parameters. The World Anti-Doping Agency (WADA) has played a leading role in the development of the Athlete Biological Passport for monitoring blood parameters such as RET#, RET%, HGB or HCT to ensure fairness among athletes.
For the sake of the patient - it is of critical importance that physicians and other healthcare personnel are able to confidently rely on laboratory test results in order to make meaningful and safe decisions about the diagnosis and treatment of patients entrusted to their care.